Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Physician Recommended Nutriceuticals
With
Rothman Institute Orthopedics
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥18 and ≤ 90 at the time of informed consent.
Subjects with symptomatic moderate arthritis of the knee defined as per
Kellgren-Lawrence grade II or III (Appendix B). Subjects with bilateral arthritis of the knee will also be recruited, but only one knee will be enrolled into the study.
Ability to walk 50 feet unassisted.
Lequesne's Functional Index score greater than 7 points
You may not be if
Subjects with systemic inflammatory conditions such as inflammatory bowel disease, psoriasis, eczema, and others
Subjects with seropositive or sero-negative inflammatory arthritis of the knee such as rheumatoid arthritis or ankylosing spondylitis.
Subjects taking hormone replacement therapy
Intra-articular corticosteroid injections 3 weeks prior to enrollment.
Hypersensitivity to fish oil.
Hypersensitivity to non-steroidal anti-inflammatory drugs, abnormal liver of kidney function tests, history of peptic ulceration and upper gastrointestinal hemorrhage, congestive heart failure, Hypertension (BP\>140/90), cancer and hyperkalemia.
Major abnormal findings on complete blood count, history of coagulopathies, hematological or neurological disorders.
High alcohol intake (\>2 standard drinks per day). Pregnant, breastfeeding or planning to become pregnant during the study
Subjects awaiting surgery on the affected knee within three months.
Consumption of any other vitamins/supplements will be allowed, provided the dose is not increased, and same brand is continued with. Also, the regimen should not contain the same active compounds tested in the PRN Joint health formula product.
Vitamins/supplements cannot be introduced during a subject's participation in the study.